1. Home
  2. MDXH vs CXDO Comparison

MDXH vs CXDO Comparison

Compare MDXH & CXDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXH
  • CXDO
  • Stock Information
  • Founded
  • MDXH 2003
  • CXDO 1995
  • Country
  • MDXH Belgium
  • CXDO United States
  • Employees
  • MDXH N/A
  • CXDO N/A
  • Industry
  • MDXH
  • CXDO Telecommunications Equipment
  • Sector
  • MDXH
  • CXDO Telecommunications
  • Exchange
  • MDXH Nasdaq
  • CXDO Nasdaq
  • Market Cap
  • MDXH 203.4M
  • CXDO 185.3M
  • IPO Year
  • MDXH 2021
  • CXDO 1998
  • Fundamental
  • Price
  • MDXH $3.28
  • CXDO $5.87
  • Analyst Decision
  • MDXH Strong Buy
  • CXDO Strong Buy
  • Analyst Count
  • MDXH 3
  • CXDO 4
  • Target Price
  • MDXH $7.67
  • CXDO $9.13
  • AVG Volume (30 Days)
  • MDXH 333.0K
  • CXDO 219.4K
  • Earning Date
  • MDXH 11-12-2025
  • CXDO 11-04-2025
  • Dividend Yield
  • MDXH N/A
  • CXDO N/A
  • EPS Growth
  • MDXH N/A
  • CXDO 201.70
  • EPS
  • MDXH N/A
  • CXDO 0.14
  • Revenue
  • MDXH $103,069,000.00
  • CXDO $66,346,000.00
  • Revenue This Year
  • MDXH $24.78
  • CXDO $13.46
  • Revenue Next Year
  • MDXH $21.20
  • CXDO $11.27
  • P/E Ratio
  • MDXH N/A
  • CXDO $41.49
  • Revenue Growth
  • MDXH 21.68
  • CXDO 12.91
  • 52 Week Low
  • MDXH $1.35
  • CXDO $3.75
  • 52 Week High
  • MDXH $5.33
  • CXDO $7.65
  • Technical
  • Relative Strength Index (RSI)
  • MDXH 26.74
  • CXDO 37.84
  • Support Level
  • MDXH $2.75
  • CXDO $6.41
  • Resistance Level
  • MDXH $4.98
  • CXDO $7.65
  • Average True Range (ATR)
  • MDXH 0.28
  • CXDO 0.44
  • MACD
  • MDXH -0.17
  • CXDO -0.12
  • Stochastic Oscillator
  • MDXH 23.45
  • CXDO 0.27

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

About CXDO Crexendo Inc.

Crexendo Inc is a provider of cloud communications, UCaaS, call centers, collaboration services, and other cloud business services. The company operates through two segments: Cloud telecommunications and Software Solutions. Its cloud telecommunications segment offers hardware, software, and unified communication solutions for businesses using IP or cloud technology over any high-speed Internet connection. The Software Solutions segment is involved in revenue generation from software licenses, software maintenance support, and professional services. It generates subscription and maintenance support revenue from customer support and other supportive services. The company offers warranties on its products. It derives a majority of its revenue from the Cloud telecommunications segment.

Share on Social Networks: